Sanjay Ahuja Appointed CEO and Medical Director of Innovative Hematology
Sanjay Ahuja, Chief Medical Officer, CEO and Medical Director of Innovative Hematology, Inc., shared Innovative Hematology, Inc.‘s post on LinkedIn:
“I am deeply grateful for this opportunity, and both honored and humbled by the responsibility it carries.
As I reflect on this moment, I’m reminded that none of us walks this path alone. We stand on the shoulders of those who came before us, lean on those who walk alongside us, and have a responsibility to lift those who follow.
Thankful for the mentors, colleagues, and teams who have made this journey possible
As I look ahead, I’m inspired by the opportunity to build, to serve, and to create something that meaningfully improves the lives of our patients we are so privileged to serve.
The work continues—and the best is still ahead.”
Innovative Hematology, Inc. shared a post on LinkedIn:
“Today marks Dr. Sanjay Ahuja‘s first day as Medical Director and CEO of Innovative Hematology.
As we look ahead, our focus now is clear:
to build on the strong foundation already in place, strengthen the continuity of care our patients depend on, and position IHI for thoughtful and sustainable growth.
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care